Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).

N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S

Open source

DOI
10.3892/mco.2026.2964
Published
2026 Sep
Container
Molecular and clinical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/mco.2026.2964,
  title = {Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).},
  author = {N S and Mv C and Upadhyay A and Sonone P and Dharmadhikari S and Puppalwar G and Khandhedia C and Mane A and Mehta S},
  year = {2026},
  journal = {Molecular and clinical oncology},
  doi = {10.3892/mco.2026.2964},
  url = {https://doi.org/10.3892/mco.2026.2964}
}

RIS

TY  - JOUR
TI  - Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).
AU  - N S
AU  - Mv C
AU  - Upadhyay A
AU  - Sonone P
AU  - Dharmadhikari S
AU  - Puppalwar G
AU  - Khandhedia C
AU  - Mane A
AU  - Mehta S
PY  - 2026
JO  - Molecular and clinical oncology
DO  - 10.3892/mco.2026.2964
UR  - https://doi.org/10.3892/mco.2026.2964
ER  - 

APA

S, N., C, M., A, U., P, S., S, D., G, P., C, K., A, M., & S, M. (2026). Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).. Molecular and clinical oncology. https://doi.org/10.3892/mco.2026.2964

Source records